- REACT validated: methylphenidate effects on dopamine-enriched networks correlate with individual striatal dopamine synthesis and reward prediction error signalling.
- Spatial collinearity between molecular targets limits selective mapping of neurotransmitter systems in molecular-enriched fMRI.
- State-dependent task effects and need for pharmacological blocking studies are essential to establish causal molecular selectivity.
Imaging Neurosci (Camb). 2026 Mar 18;4:IMAG.a.1175. doi: 10.1162/IMAG.a.1175. eCollection 2026.
ABSTRACT
Molecular-enriched fMRI promises to bridge the gap between neurotransmitter systems and macro-scale network dynamics, yet empirical support has remained elusive. Commenting on van den Bosch and Cools (2025), we evaluate the first attempt to validate Receptor-Enriched Analysis of functional Connectivity by Targets (REACT) against individual-level PET data. They found that the effects of methylphenidate on dopamine-enriched networks, but not noradrenaline-enriched networks, tracked individual differences in striatal dopamine synthesis capacity and reward prediction error signaling. While establishing the validity of molecular-enriched networks for this specific use case, the study also exposes critical methodological boundary conditions. We discuss the constraints imposed by spatial collinearity between molecular targets, the influence of state-dependent effects in task-based paradigms, and the necessity of pharmacological blocking studies for establishing causal selectivity. Finally, we look to the future of molecular-informed functional imaging.
PMID:41868969 | PMC:PMC13000545 | DOI:10.1162/IMAG.a.1175
Share Evidence Blueprint
Save to Google Notes

Search Google Scholar
⭐ My Revision List

